Wutah dodolan YoY sajrone rolas wulan kepungkur: Organovo Corp (ONVO)

Logo grafis Organovo Holdings, Inc. (ONVO)

Organovo Holdings, Inc. (ONVO) collaborates with laboratories to test drugs on bioprinted tissues, although the product technology upgrade stage is only beginning to build growth potential. The year-over-year sales growth rate for the TTM resolves this dissonance, with the current level standing at -85.90. Consequently, Organovo Holdings, Inc. (ONVO) is scaling the implementation of 3D models to study metabolic pathologies, aiming to capture the B2B segment of the pharmaceutical market.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Organovo Holdings Inc (ONVO) kanggo 11.02.2024 - 20.02.2024

Ringkesan rincian data analitis Organovo Corp (ONVO)

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:Organovo Holdings Inc
Produk seri Organovo Holdings Inc

For Organovo Holdings, Inc. (ONVO), a leader in 3D bioprinting, revenue growth rates over the last twelve months reflect the actual scaling speed of demand for NovoGen technology. By analyzing year-over-year sales dynamics using the TTM methodology, an investor assesses the percentage change in revenue relative to the previous year, which confirms the commercial demand for bioprinted tissues within the R&D sectors of pharma behemoths and determines the fundamental stability of the business.

Karo sapa Organovo Holdings, Inc. saingan

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MiMedx Group, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) MBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur Altimmune, Inc. ALT|Wutah dodolan YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Wutah pendapatan taun lumaku|BIOA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur BMEA (Biomea Fusion)|QNCX (quincetx.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Fractyl - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|VTVT (vTv Therapeutics Inc) - Wutah dodolan YoY (TTM)|Agape ATP - Wutah dodolan taun lumaku|Wutah pendapatan YoY sajrone 12 wulan kepungkur PLUR (Pluri Inc)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Synlogic Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Wutah pendapatan taun lumaku|Spruce Biosciences Inc. - Wutah dodolan YoY (TTM)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Lumos Pharma - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)